Sesen Bio, Inc.
SESN · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $26,068 | $6,079 | $7,430 | $7,980 |
| - Cash | $17,909 | $112,553 | $162,636 | $52,389 |
| + Debt | $2,481 | $0 | $0 | $0 |
| Enterprise Value | $10,640 | -$106,474 | -$155,206 | -$44,409 |
| Revenue | $0 | $40,000 | $26,544 | $11,236 |
| % Growth | -100% | 50.7% | 136.2% | – |
| Gross Profit | $0 | $40,000 | $26,544 | $11,236 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | $0 | -$50,840 | -$8,549 | -$21,077 |
| % Margin | – | -127.1% | -32.2% | -187.6% |
| Net Income | -$60,477 | -$19,884 | -$336 | -$22,397 |
| % Margin | – | -49.7% | -1.3% | -199.3% |
| EPS Diluted | -1.46 | -1.99 | -0.037 | -3.8 |
| % Growth | 26.6% | -5,293% | 99% | – |
| Operating Cash Flow | -$59,917 | $24,895 | -$68,878 | -$30,837 |
| Capital Expenditures | -$123 | $0 | -$4 | -$8 |
| Free Cash Flow | -$60,040 | $24,895 | -$68,882 | -$30,845 |